Systemic lupus erythematosus MRI: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Mmir (talk | contribs)
CMEAdmin, CMEUser, Bureaucrats, bureaucrats, nocaptcha, smwadministrator, Administrators, Widget editors
14,850 edits
Mmir (talk | contribs)
CMEAdmin, CMEUser, Bureaucrats, bureaucrats, nocaptcha, smwadministrator, Administrators, Widget editors
14,850 edits
Line 39: Line 39:
!Organ
!Organ
!Disease
!Disease
!Description
!CT
!MRI
!MRI
!SONO
!SONO
|-
|-
| rowspan="8" |Gastrointestinal system
| rowspan="4" |Gastrointestinal system
|[[Dysphagia]]
|
*Barium swallow/esophagography
**Oesophageal stricture
*** Peptic strictures that appear as smooth, tapered narrowing in the distal esophagus
** Esophageal dilatation 
|
|
|
|-
|[[Intestinal pseudo-obstruction]]
|
*dilated bowel loops with or without the presence of fluid levels
*Erect chest radiographs for perforation evaluating
|
* dilated bowel loops with or without the presence of fluid levels
** a distinct transition point where bowel calibre changes from normal to abnormal
** dilated bowel loops proximal to the transition point
*** small bowel >3.5 cm
*** large bowel >5 cm
** collapsed or normal calibre bowel distal to the transitional point
** bowel wall thickening
** Obstruction:
*** pneumoperitoneum indicating perforation
*** bowel ischaemia
|
|
|-
|[[Hepatitis]]
|[[Hepatitis]]
|
**
|
* Hepatic granulomas
* Nonspecific, ranging from normal to hepatomegaly and cirrhosis.
** Discrete, sharply defined nodular lesions within the liver
|
|
* nodules ranging around 0.5-4.5 cm in diameter 
* nodules ranging around 0.5-4.5 cm in diameter 
Line 88: Line 51:
|-
|-
|[[Acute pancreatitis]]
|[[Acute pancreatitis]]
|
*
|Abnormalities that may be seen in the pancreas include:
* typical findings
** focal or diffuse parenchymal enlargement
** changes in density because of oedema
** indistinct pancreatic margins owing to inflammation
** surrounding retroperitoneal fat stranding
* liquefactive necrosis of pancreatic parenchyma
** lack of parenchymal enhancement
** often multifocal
* infected necrosis
** difficult to distinguish from aseptic liquefactive necrosis
** the presence of gas is helpful
** FNA helpful
* abscess formation
** circumscribed fluid collection
** little or no necrotic tissues (thus distinguishing it from infected necrosis)
* haemorrhage
** high-attenuation fluid in the retroperitoneum or peripancreatic tissues
|Contrast-enhanced MR is equivalent to CT in the assessment of pancreatitis.
|Contrast-enhanced MR is equivalent to CT in the assessment of pancreatitis.


Line 132: Line 75:
* diagnosis of vascular complications, e.g. thrombosis
* diagnosis of vascular complications, e.g. thrombosis
* identify areas of necrosis which appear as hypoechoic regions
* identify areas of necrosis which appear as hypoechoic regions
|-
|Aotpsplenectomy
|If heavily calcified, the splenic remnant may be visible in the left upper quadrant.
|CT easily identifies the abnormally small and irregular splenic remnant, which is usually calcified.
|
|Ultrasound will either not be able to demonstrate a spleen at all, or identify a small irregular and shadowing nodule in the splenic bed.
|-
|Enteritis
|The main feature of enteritis is '''small bowel wall thickening'''. Low density submucosal edema can usually be differentiated from higher density mural haemorrhage or infiltration. Dilatation or strictures may or may not be present, the later if chronic.
|
|
|
|-
|-
|[[Mesenteric vascular occlusion|Mesenteric vasculitis]]
|[[Mesenteric vascular occlusion|Mesenteric vasculitis]]
|
*
|
* The '''comb sign''' refers to the hypervascular appearance of the mesentery 
* This forms linear densities on the mesenteric side of the affected segments of small bowel, which give the appearance of the teeth of a comb. 
|
|
* The '''comb sign''' refers to the hypervascular appearance of the mesentery 
* The '''comb sign''' refers to the hypervascular appearance of the mesentery 
Line 157: Line 83:
|-
|-
|[[Acute cholecystitis]]
|[[Acute cholecystitis]]
|
*
|
* gallbladder distension
* gallbladder wall thickening
* mural or mucosal hyperenhancement
* pericholecystic fluid and inflammatory fat stranding
* enhancement of the adjacent liver parenchyma due to reactive hyperaemia
* tensile gallbladder fundus sign 7
** fundus bulging the anterior abdominal wall
|MR cholangiopancreatography (MRCP) may show an impacted stone in the gallbladder neck or cystic duct as a rounded filling defect.
|MR cholangiopancreatography (MRCP) may show an impacted stone in the gallbladder neck or cystic duct as a rounded filling defect.
|
|
Line 174: Line 90:
*  
*  
|-
|-
| rowspan="7" |Pulmonary involvement
| rowspan="5" |Cardiac involvement
|Pleural effusion
|
* A lateral decubitus film can visualise small amounts of fluid layering against the dependent parietal pleura.
* PA and AP CXR:
** blunting of the costophrenic angle
** blunting of the cardiophrenic angle
** fluid within the horizontal or oblique fissures
** mediastinal shifts with large amounts of fluid
|
* May be associated with thickening of the pleura
* Fluid density
|
|echo-free space between the visceral and parietal pleura
|-
|Respiratory muscle dysfunction
|elevated hemidiaphragms at chest radiography
 
linear atelectasis and an ill-defined juxtadiaphragmatic areas of increased opacity 
 
Wiedemann HP, Matthay RA. ''Pulmonary manifestations of collagen vascular diseases.Clin Chest Med'' 1989; 10:677-696
|
|
|
|-
|[[Pneumonitis|Acute pneumonitis]]
|
*A rare and fulminant form of diffuse lung injury that generally occurs in previously healthy individuals and has a rapid onset with [[fever]], [[cough]], and [[Dyspnea|shortness of breath]].
|
|
|
|-
|[[Pulmonary hemorrhage]]
|
*Patchy bilateral and acinar areas of increased opacity, predominantly in the lower lungs
**
|
|
|
|-
|[[Pulmonary hypertension]]
|
*Elevated cardiac apex due to right ventricular hypertrophy
* enlarged right atrium
* prominent pulmonary outflow tract
* enlarged pulmonary arteries
* pruning of peripheral pulmonary vessels
|
|
|
|-
|Pulmonary emboli
|
** Fleishner sign: enlarged pulmonary artery (20%)
** Hampton hump: peripheral wedge of airspace opacity and implies lung infarction (20%)
** Westermark sign: regional oligaemia and highest positive predictive value (10%)
** pleural effusion (35%)
** knuckle sign 11
** Palla's sign17: enlarged right descending pulmonary artery
|
* filling defects within the pulmonary vasculature with acute pulmonary emboli
* vascular CT signs include
** direct pulmonary artery signs
*** complete obstruction
*** partial obstruction
*** eccentric thrombus
*** calcified thrombus - calcific pulmonary emboli
*** pulmonary arterial bands/pulmonary arterial webs 1,4-5
*** post stenotic dilatation
** signs related to pulmonary hypertension
*** enlargement of main pulmonary arteries
*** the peripheral pulmonary arteries in affected segments may be narrowed ref required
*** pulmonary arterial calcification
*** tortuous pulmonary vessels
*** right ventricular enlargement/hypertrophy
** signs of systemic collateral supply
*** enlargement of bronchial and nonbronchial systemic arteries
* Signs of chronic obstruction: webs or bands, intimal irregularities 3/ abrupt narrowing or complete obstruction of the pulmonary arteries 3 / “pouching defects” which are defined as chronic thromboembolism organised in a concave shape that “points” toward the vessel lumen
*
* parenchymal signs (often non-specific on their own):
** scars
** mosaic perfusion pattern
** focal ground-glass opacities
** bronchial anomalies
* The central filling defect from the thrombus is surrounded by a thin rim of contrast, appearing like the popular sweet, the polo mint 
|
|
|-
|Shrinking lung syndrome
|
*small but clear lungs with diaphragmatic elevation
*basal atelectasis 
|
* reduced lung volumes with diaphragmatic elevation +/- occasional basal atelectasis but without any major parenchymal lung or pleural disease 
|
|
|-
| rowspan="7" |Cardiac involvement
|[[Cardiomegaly]]
|
**Cardiac enlargement
|
|
|
|-
|Mitral stenosis
|Mitral stenosis
|
** cardiomegaly
** double right heart border (enlarged left atrium and normal right atrium)
** prominent left atrial appendage
** splaying of the subcarinal angle (>120 degrees)
|valve thickening or leaflet fixation
|
|
* mitral leaflet thickening
* mitral leaflet thickening
Line 293: Line 99:
|-
|-
|Mitral regurgitation
|Mitral regurgitation
|frontal projection
* left atrial enlargement
** convexity or straightening of the left atrial appendage just below the main pulmonary artery (along left heart border)
** double density sign: the right side of the enlarged left atrium pushes into the adjacent lung and creates an addition contour superimposed over the right heart
** elevation of the left main bronchus and splaying of the carina
* upper zone venous enlargement due to pulmonary venous hypertension
* left ventricular enlargement is also eventually present due to volume overload
|
|
|
|
|
|-
|-
|Acute pericarditis
|Acute pericarditis
|
*
|enhancement of the thickened pericardium generally indicates inflammation 
|The normal pericardial thickness is considered 2 mm while a thickness of over 4 mm suggests a pericarditis 
|The normal pericardial thickness is considered 2 mm while a thickness of over 4 mm suggests a pericarditis 
|
|
|-
|-
|Pericardial effuson
|Pericardial effuson
|
* globular enlargement of the cardiac shadow giving a water bottle configuration
* Lateral CXR may show a vertical opaque line (pericardial fluid) separating a vertical lucent line directly behind sternum (epicardial fat) anteriorly from a similar lucent vertical lucent line (pericardial fat) posteriorly; this is known as the Oreo cookie sign
*
|Fluid density material is seen surrounding the heart
|Fluid density material is seen surrounding the heart
|Fluid density material is seen surrounding the heart
|Echocardiography is the method of choice to confirm the diagnosis, estimate the volume of fluid and most importantly assess the haemodynamic impact of the effusion
|Echocardiography is the method of choice to confirm the diagnosis, estimate the volume of fluid and most importantly assess the haemodynamic impact of the effusion
|-
|-
|[[Myocarditis]]
|[[Myocarditis]]
|
*
|
|
|
* regional or global wall motion abnormalities are common, but nonspecific (biventricular wall motion abnormality, however, is the main predictor of death or transplantation)
* regional or global wall motion abnormalities are common, but nonspecific (biventricular wall motion abnormality, however, is the main predictor of death or transplantation)
Line 330: Line 117:
|
|
|-
|-
|[[Coronary heart disease|Coronary artery disease]]
| rowspan="2" |Neurological involvement
|
*
|
* coronary CT angiography (cCTA)
* can show the amount of stenosis
|
|
|-
| rowspan="3" |Neurological involvement
|[[Cognitive-shifting|Cognitive dysfunction]]
|
*The mental status of SLE patients can be temporarily affected by multiple, transient metabolic and systemic processes
|
|
|
|-
|[[Stroke]]
|[[Stroke]]
|
*
|
* Early sign: a hyperdense segment of a vessel, representing direct visualisation of the intravascular thrombus / embolus and as such is visible immediately
* Early hyperacute: loss of grey-white matter differentiation, and hypoattenuation of deep nuclei
* cortical hypodensity with associated parenchymal swelling with resultant gyral effacement
* elevation of the attenuation of the cortex. This is known as the CT fogging phenomenon
* a region of low density with negative mass effect. Cortical mineralisation can also sometimes be seen appearing hyperdense.
*
|
|
* the affected parenchyma appears normal on other sequences, although changes in flow will be detected (occlusion on MRA) and the thromboembolism may be detected (e.g. on SWI). Slow or stagnant flow in vessels may also be detected as a loss of normal flow void and high signal 
* the affected parenchyma appears normal on other sequences, although changes in flow will be detected (occlusion on MRA) and the thromboembolism may be detected (e.g. on SWI). Slow or stagnant flow in vessels may also be detected as a loss of normal flow void and high signal 
Line 363: Line 125:
|-
|-
|[[Neuropathies]]
|[[Neuropathies]]
|
*
|
|
|
* Optic neuritis:
* Optic neuritis:
Line 373: Line 132:
|
|
|Autoimmune encephalitis
|Autoimmune encephalitis
|
|
|mesial temporal lobes and limbic systems, typically manifested by cortical thickening and increased T2/FLAIR signal intensity of these regions. Bilateral involvement is most common (60%), although often asymmetric
|mesial temporal lobes and limbic systems, typically manifested by cortical thickening and increased T2/FLAIR signal intensity of these regions. Bilateral involvement is most common (60%), although often asymmetric
Patchy areas of enhancement
Patchy areas of enhancement
Line 381: Line 138:
|
|
|Raynaud phenomen
|Raynaud phenomen
|
|
|contrast-enhanced MR angiography may also reveal characteristic narrowing and tapering of digital vessels 
|contrast-enhanced MR angiography may also reveal characteristic narrowing and tapering of digital vessels 
|Doppler sonography:
|Doppler sonography:
Line 389: Line 144:
|
|
|Myositis
|Myositis
|
|
|'''Intramuscular oedema''' (increased high T2/STIR signal)
|'''Intramuscular oedema''' (increased high T2/STIR signal)
|
|
Line 396: Line 149:
| rowspan="4" |Musculoskeletal involvement
| rowspan="4" |Musculoskeletal involvement
|[[Arthritis]]
|[[Arthritis]]
|
*Mostly symmetrical and non-erosive
*Arthralgias
*Effusions
*Decreased range of motion of both small and large joints
*Morning stiffness
|
|
|
|
|
|-
|-
|[[Osteonecrosis]] ([[Avascular necrosis]])
|[[Osteonecrosis]] ([[Avascular necrosis]])
|
*Most common in the femoral head
*Can involve humeral head, tibial plateau, and scaphoid navicular
*Usually bilateral and is often asymptomatic
*Glucocorticoids treatment is associated with the greatest risk of developing the disease
|
|
|
|
|
|-
|-
|Subcutaneous nodules
|Subcutaneous nodules
|
*In association with active disease
|
|
|
|
|
|-
|-
|Osteoporosis
|Osteoporosis
|
*Mostly due to [[glucocorticoid]] usage
*Loss of height
*Sudden back pain
|
|
|
|
|

Revision as of 13:51, 17 July 2017

Systemic lupus erythematosus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Systemic lupus erythematosus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Lupus and Quality of Life

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Systemic lupus erythematosus MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Systemic lupus erythematosus MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Systemic lupus erythematosus MRI

on Systemic lupus erythematosus MRI

Systemic lupus erythematosus MRI in the news

Blogs onSystemic lupus erythematosus MRI

Directions to Hospitals Treating Systemic lupus erythematosus

Risk calculators and risk factors for Systemic lupus erythematosus MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Joint and synovial evaluation

Reveal erosive changes and abnormalities of the soft tissues more often, including:

  • Capsular swelling
  • Proliferative tenosynovitis
  • Synovial overgrowth
Neurological evaluation

MRI is more sensitive than CT, and may reveal the following abnormalities:

  • Focal neurological defects
  • White matter lesions
  • Periventricular hyperintensities
  • Detects clinically silent lesions
Cardialogical evaluation
  • Cine cardiac MR imaging as an noninvasive tool for evaluating
    • Abnormal flow patterns
    • Ventricular dimensions
    • Stroke volume
    • Regional myocardial function
Bone evaluation
  • Avascular necrosis (AVN)
    • Lack of enhancement and devascularized areas on gadolinium-enhanced MR imaging 
    • Bone marrow edema on MRI with  
    • Low-signal-intensity marginal areas on standard spin-echo T1- and T2-weighted images 
    • Intermediate to high signal intensity inside bone tissue on T2-weighted images, producing a line of low signal intensity with an adjacent high-signal-intensity line 
    • High signal intensity on T2-weighted images due to subchondral fractures that may be accompanied by fluid signal intensity or edema 
    • Low signal intensity on T2-weighted images due to collapse of the articular surface 
  • Early or subtle insufficiency fractures especially on T2-weighted MR imaging
    • In characteristic stress locations insufficiency fractures may appear as areas of high signal intensity due to bone marrow edema
Organ Disease MRI SONO
Gastrointestinal system Hepatitis
  • nodules ranging around 0.5-4.5 cm in diameter 
    • T2: nonspecific, increased periportal oedema 4
    • MRCP: primary sclerosing cholangitis (PSC) should be excluded
Acute pancreatitis Contrast-enhanced MR is equivalent to CT in the assessment of pancreatitis.

Abnormalities that may be seen in the pancreas include:

  • typical findings
    • focal or diffuse parenchymal enlargement
    • changes in density because of oedema
    • indistinct pancreatic margins owing to inflammation
    • surrounding retroperitoneal fat stranding
  • liquefactive necrosis of pancreatic parenchyma
    • lack of parenchymal enhancement
    • often multifocal
  • infected necrosis
    • difficult to distinguish from aseptic liquefactive necrosis
    • the presence of gas is helpful
    • FNA helpful
  • abscess formation
    • circumscribed fluid collection
    • little or no necrotic tissues (thus distinguishing it from infected necrosis)
  • haemorrhage
    • high-attenuation fluid in the retroperitoneum or peripancreatic tissues
  • to identify gallstones as a possible cause
  • diagnosis of vascular complications, e.g. thrombosis
  • identify areas of necrosis which appear as hypoechoic regions
Mesenteric vasculitis
  • The comb sign refers to the hypervascular appearance of the mesentery 
  • This forms linear densities on the mesenteric side of the affected segments of small bowel, which give the appearance of the teeth of a comb. 
Acute cholecystitis MR cholangiopancreatography (MRCP) may show an impacted stone in the gallbladder neck or cystic duct as a rounded filling defect.
  • gallbladder wall thickening (>3 mm) and pericholecystic fluid 
  • Positive Murphy sign
  • gallbladder distension
Cardiac involvement Mitral stenosis
  • mitral leaflet thickening
  • reduced diastolic opening
  • abnormal valve motion toward the left ventricular outflow tract
Mitral regurgitation
Acute pericarditis The normal pericardial thickness is considered 2 mm while a thickness of over 4 mm suggests a pericarditis 
Pericardial effuson Fluid density material is seen surrounding the heart Echocardiography is the method of choice to confirm the diagnosis, estimate the volume of fluid and most importantly assess the haemodynamic impact of the effusion
Myocarditis
  • regional or global wall motion abnormalities are common, but nonspecific (biventricular wall motion abnormality, however, is the main predictor of death or transplantation)
  • pericardial effusion is reported in ~45% (range 32-57%) of patients with myocarditis
    • regional vasodilatation and increased blood volume due to the inflammation in myocarditis causes early postcontrast enhancement
Neurological involvement Stroke
  • the affected parenchyma appears normal on other sequences, although changes in flow will be detected (occlusion on MRA) and the thromboembolism may be detected (e.g. on SWI). Slow or stagnant flow in vessels may also be detected as a loss of normal flow void and high signal 
  • after 6 hours, high T2 signal will be detected
Neuropathies
  • Optic neuritis:
    • Typically findings are most easily identified in the retrobulbar intra-orbital segment of the optic nerve, which appears swollen, with high T2 signal. High T2 signal persists and may be permanent; chronically the nerve will appear atrophied rather than swollen. Contrast enhancement of the nerve, best seen with fat-suppressed T1 coronal images, is seen in >90% of patients if scanned within 20 days of visual loss
Autoimmune encephalitis mesial temporal lobes and limbic systems, typically manifested by cortical thickening and increased T2/FLAIR signal intensity of these regions. Bilateral involvement is most common (60%), although often asymmetric

Patchy areas of enhancement

Raynaud phenomen contrast-enhanced MR angiography may also reveal characteristic narrowing and tapering of digital vessels  Doppler sonography:

flow volume and vessel size irregularities 

Myositis Intramuscular oedema (increased high T2/STIR signal)
Musculoskeletal involvement Arthritis
Osteonecrosis (Avascular necrosis)
Subcutaneous nodules
Osteoporosis

Examples of MRI Findings in Systemic Lupus Erythematosus

References

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Systemic_lupus_erythematosus_MRI&oldid=1326587"